Delivery Order SPE2DB24D2205-SPE2DB25FEBMR
- Not listed
- The Defense Logistics Agency awarded a $2,624.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitive award, which carries no set-aside designation, represents a pharmaceutical supply delivery to support federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $3,035.43 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg on November 6, 2025, with completion scheduled for November 7, 2025. This competitively awarded, firm fixed-price delivery order reflects the agency's ongoing pharmaceutical procurement needs. The award was issued under a non-set-aside basis, indicating open competition among qualified vendors. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Multaq 400 mg tablets (60-count units) with a ceiling value of $5,600.41. This non-competitive, firm fixed-price delivery order was awarded on April 21, 2025, with an ultimate completion date of April 22, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,487.82 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order represents a non-set-aside award issued under competitive procedures. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $3,200.00 for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, with performance completed by August 1, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $4,560.24 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60 count). This competitive award, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed price delivery order with no set-aside designation. The contractor will perform this work from its corporate headquarters in Conshohocken, Pennsylvania, where it maintains operations as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) valued at $3,359.77, with an ultimate completion date of September 11, 2025. This competitive award, issued September 10, 2025, utilizes firm fixed-price pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a delivery order valued at $3,091.39 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and represents a pharmaceutical delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $14,473.05 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. The contract, awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $14,438.67 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count) on November 5, 2025, with completion expected by November 6, 2025. This is a firm fixed-price delivery order under a non-competitive set-aside arrangement, with fulfillment occurring at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEBMRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg with a ceiling value of $20,863.60. This competitive, firm fixed-price delivery order was issued on April 25, 2025, with an ultimate completion date of April 28, 2025. The award is performance-based in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor contract valued at $999,999,999.00 and extending through December 2026. This IDC provides a flexible vehicle for supplying a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract supports multiple customer agencies, including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen Drug Corp as a key supplier within the DLA's pharmaceutical procurement strategy for federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.9k | 4/25/25 |